Journal: Journal of Biomedical Science

Article Title: Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine

doi: 10.1186/s12929-019-0563-4

Figure Lengend Snippet: FE-SEM images of ZnO-NPs ( a ) and ZnO-PEG-NPs ( b ); TEM image of ZnO-PEG-NPs ( c )

Article Snippet: The powdered zinc oxide nanoparticles were purchased from US Research Nanomaterials (USA; Product Number: US3590).

Techniques:

Journal: Journal of Biomedical Science

Article Title: Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine

doi: 10.1186/s12929-019-0563-4

Figure Lengend Snippet: Powder X-ray Diffraction Pattern of ZnO-NPs

Article Snippet: The powdered zinc oxide nanoparticles were purchased from US Research Nanomaterials (USA; Product Number: US3590).

Techniques:

Journal: Journal of Biomedical Science

Article Title: Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine

doi: 10.1186/s12929-019-0563-4

Figure Lengend Snippet: Thermogravimetric analysis: a ) unPEGylated ZnO-NPs; b ) PEGylated ZnO-NPs

Article Snippet: The powdered zinc oxide nanoparticles were purchased from US Research Nanomaterials (USA; Product Number: US3590).

Techniques:

Journal: Journal of Biomedical Science

Article Title: Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine

doi: 10.1186/s12929-019-0563-4

Figure Lengend Snippet: Cytotoxicity of ZnO-NPs ( a ), ZnO-PEG-NPs ( b ), polyethylene glycol ( c ), and oseltamivir ( d ) on MDCK-SIAT1 cells. * Statistically significant ( p < 0.05). ** Statistically significant ( p = 0.003). ** Statistically significant ( p = 0.0005). **** Highly statistically significant ( p = 0.0001). Error bars represent the confidence interval for the mean ( n = 3) at the 95% level

Article Snippet: The powdered zinc oxide nanoparticles were purchased from US Research Nanomaterials (USA; Product Number: US3590).

Techniques:

Journal: Journal of Biomedical Science

Article Title: Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine

doi: 10.1186/s12929-019-0563-4

Figure Lengend Snippet: Assessment of the post-exposure antiviral activity of ZnO-NPs, ZnO-PEG-NPs, polyethylene glycol, and oseltamivir on the titer of H1N1 influenza virus by TCID50 assay. * Statistically significant ( p < 0.0001). Error bars represent the confidence interval for the mean ( n = 3) at the 95% level

Article Snippet: The powdered zinc oxide nanoparticles were purchased from US Research Nanomaterials (USA; Product Number: US3590).

Techniques: Activity Assay, TCID50 Assay

Journal: Journal of Biomedical Science

Article Title: Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine

doi: 10.1186/s12929-019-0563-4

Figure Lengend Snippet: The inhibitory rates of the four compounds against H1N1 influenza virus determined by Real-Time PCR assay regarding to the post-exposure antiviral activity. According to the one-way ANOVA followed by Tukey’s multiple comparisons test, there were significant differences among the groups ( p < 0.0001), except for ZnO-NPs vs. ZnO-PEG-NPs at the concentration of 25 μg/mL. Error bars represent the confidence interval for the mean ( n = 3) at the 95% level

Article Snippet: The powdered zinc oxide nanoparticles were purchased from US Research Nanomaterials (USA; Product Number: US3590).

Techniques: Real-time Polymerase Chain Reaction, Activity Assay, Concentration Assay

Journal: Journal of Biomedical Science

Article Title: Inhibition of H1N1 influenza virus infection by zinc oxide nanoparticles: another emerging application of nanomedicine

doi: 10.1186/s12929-019-0563-4

Figure Lengend Snippet: Immunofluorescence staining for detection of H1N1 influenza virus antigens in the MDCK-SIAT1 cells. ( a ) Cell control, ( b ) Virus control, ( c ) Infected cells treated with ZnO-NPs (75 μg/ml) and ( d ) 200 μg/ml ZnO-PEG-NPs at 24 h post infection

Article Snippet: The powdered zinc oxide nanoparticles were purchased from US Research Nanomaterials (USA; Product Number: US3590).

Techniques: Immunofluorescence, Staining, Infection

Journal: MethodsX

Article Title: A green synthesis of zinc oxide nanoparticles using Musa Paradisiaca and Rooibos extracts

doi: 10.1016/j.mex.2022.101892

Figure Lengend Snippet: (a) Ultraviolet-visible (UV-Vis) spectrum of the green synthesised zinc oxide nanoparticles (b) X-ray diffraction (XRD) patterns of the green zinc oxide nanoparticles.

Article Snippet: Kirby-Bauer disc diffusion was used to test the antimicrobial activity of the green synthesized ZnO NPs against Candidia albicans (ATCC 90028).

Techniques:

Journal: MethodsX

Article Title: A green synthesis of zinc oxide nanoparticles using Musa Paradisiaca and Rooibos extracts

doi: 10.1016/j.mex.2022.101892

Figure Lengend Snippet: High-resolution scanning electron microscopy (HRSEM) micrographs of the green synthesised zinc oxide nanoparticles at 25.00 K X.

Article Snippet: Kirby-Bauer disc diffusion was used to test the antimicrobial activity of the green synthesized ZnO NPs against Candidia albicans (ATCC 90028).

Techniques: Electron Microscopy

Journal: MethodsX

Article Title: A green synthesis of zinc oxide nanoparticles using Musa Paradisiaca and Rooibos extracts

doi: 10.1016/j.mex.2022.101892

Figure Lengend Snippet: (a) FTIR analysis of the green zinc oxide nanoparticles, in comparison to all extracts combined (b) HRTEM of the green zinc oxide nanoparticles.

Article Snippet: Kirby-Bauer disc diffusion was used to test the antimicrobial activity of the green synthesized ZnO NPs against Candidia albicans (ATCC 90028).

Techniques: Comparison

Journal: MethodsX

Article Title: A green synthesis of zinc oxide nanoparticles using Musa Paradisiaca and Rooibos extracts

doi: 10.1016/j.mex.2022.101892

Figure Lengend Snippet: HRSEM spectroscopy and elemental composition, as well as crystalline structure description of the green zinc oxide nanoparticles.

Article Snippet: Kirby-Bauer disc diffusion was used to test the antimicrobial activity of the green synthesized ZnO NPs against Candidia albicans (ATCC 90028).

Techniques: Spectroscopy

Journal: MethodsX

Article Title: A green synthesis of zinc oxide nanoparticles using Musa Paradisiaca and Rooibos extracts

doi: 10.1016/j.mex.2022.101892

Figure Lengend Snippet: Zones of inhibition for CHX (A, D, G); ZnO NPs (B, E, H); and [Zn (NO 3 ) 2 ·6H 2 O] (C, F, I).

Article Snippet: Kirby-Bauer disc diffusion was used to test the antimicrobial activity of the green synthesized ZnO NPs against Candidia albicans (ATCC 90028).

Techniques: Inhibition

Journal: MethodsX

Article Title: A green synthesis of zinc oxide nanoparticles using Musa Paradisiaca and Rooibos extracts

doi: 10.1016/j.mex.2022.101892

Figure Lengend Snippet:

Article Snippet: Kirby-Bauer disc diffusion was used to test the antimicrobial activity of the green synthesized ZnO NPs against Candidia albicans (ATCC 90028).

Techniques:

Journal: PLoS ONE

Article Title: Bulk and nanoparticles of zinc oxide exerted their beneficial effects by conferring modifications in transcription factors, histone deacetylase, carbon and nitrogen assimilation, antioxidant biomarkers, and secondary metabolism in soybean

doi: 10.1371/journal.pone.0256905

Figure Lengend Snippet: The effect of BZnO or ZnO NPs and application methods on various characteristics related to growth, yield, and Zn concentration.

Article Snippet: ZnO NPs (CAS Number: 1314-13-2; Stock number: US3590) were supplied by US research nanomaterials, Inc; 3302 Twig Leaf Lane Houston, TX 77084, USA).

Techniques: Concentration Assay

Journal: PLoS ONE

Article Title: Bulk and nanoparticles of zinc oxide exerted their beneficial effects by conferring modifications in transcription factors, histone deacetylase, carbon and nitrogen assimilation, antioxidant biomarkers, and secondary metabolism in soybean

doi: 10.1371/journal.pone.0256905

Figure Lengend Snippet: The effects of BZnO or ZnONP in two application methods (foliar and supplementation of nutrient solution) on the transcription of several genes, including EREB [a], bHLH [b], R2R3MYB [c], HSF -34 [d], WRKY1 [e], and MAPK1 [f]; The treatment groups: C: Control; BZnO-F: Foliar application of BZnO; ZnO NPs-F: Foliar application of ZnO NPs; BZnO-S: Supplementation of nutrient solution with BZnO; ZnO NPs-S: Supplementation of nutrient solution with ZnO NPs; Different letters on the columns refer to statistically significant differences according to Tukey’s multiple comparisons test. A comparison between the two BZnO and ZnO NPs groups at the same method is presented by placing an asterisk [*] on the line, while asterisks [*] on the dashed lines define the comparison between two ZnO NPs-F and ZnO NPs-S groups. ns: Non-significant; *: 0.01 < p ≤ 0.05; **: 0.001 < p ≤ 0.01; ***: 0.0001 < p ≤ 0.001; ****: p ≤ 0.0001.

Article Snippet: ZnO NPs (CAS Number: 1314-13-2; Stock number: US3590) were supplied by US research nanomaterials, Inc; 3302 Twig Leaf Lane Houston, TX 77084, USA).

Techniques:

Journal: PLoS ONE

Article Title: Bulk and nanoparticles of zinc oxide exerted their beneficial effects by conferring modifications in transcription factors, histone deacetylase, carbon and nitrogen assimilation, antioxidant biomarkers, and secondary metabolism in soybean

doi: 10.1371/journal.pone.0256905

Figure Lengend Snippet: The transcriptional responses of HDA3 [a] and CAT [b] genes following the BZnO or ZnONP treatments. The treatment groups: C: Control; BZnO-F: Foliar application of BZnO; ZnO NPs-F: Foliar application of ZnO NPs; BZnO-S: Supplementation of nutrient solution with BZnO; ZnO NPs-S: Supplementation of nutrient solution with ZnO NPs; Different letters on the columns refer to statistically significant differences according to Tukey’s multiple comparisons test. A comparison between the two BZnO and ZnO NPs groups at the same method is presented by placing an asterisk [*] on the line, while asterisks [*] on the dashed lines define the comparison between two ZnO NPs-F and ZnO NPs-S groups. ns: Non-significant; *: 0.01 < p ≤ 0.05; **: 0.001 < p ≤ 0.01; ***: 0.0001 < p ≤ 0.001; ****: p ≤ 0.0001.

Article Snippet: ZnO NPs (CAS Number: 1314-13-2; Stock number: US3590) were supplied by US research nanomaterials, Inc; 3302 Twig Leaf Lane Houston, TX 77084, USA).

Techniques:

Journal: PLoS ONE

Article Title: Bulk and nanoparticles of zinc oxide exerted their beneficial effects by conferring modifications in transcription factors, histone deacetylase, carbon and nitrogen assimilation, antioxidant biomarkers, and secondary metabolism in soybean

doi: 10.1371/journal.pone.0256905

Figure Lengend Snippet: The BZnO or ZnONP-mediated changes in several physiological traits, including Chl a [a], Chl b [b], carotenoids [c], nitrate reductase [d], proline [e], peroxidase activity [f], catalase activity [g], PAL activity [h], and soluble phenols [i]; The treatment groups: C: Control; BZnO-F: Foliar application of BZnO; ZnO NPs-F: Foliar application of ZnO NPs; BZnO-S: Supplementation of nutrient solution with BZnO; ZnO NPs-S: Supplementation of nutrient solution with ZnO NPs; Different letters on the columns refer to statistically significant differences according to Tukey’s multiple comparisons test. A comparison between the two BZnO and ZnO NPs groups at the same method is presented by placing an asterisk [*] on the line, while asterisks [*] on the dashed lines define the comparison between two ZnO NPs-F and ZnO NPs-S groups. ns: Non-significant; *: 0.01 < p ≤ 0.05; **: 0.001 < p ≤ 0.01; ***: 0.0001 < p ≤ 0.001; ****: p ≤ 0.0001.

Article Snippet: ZnO NPs (CAS Number: 1314-13-2; Stock number: US3590) were supplied by US research nanomaterials, Inc; 3302 Twig Leaf Lane Houston, TX 77084, USA).

Techniques: Activity Assay